Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, Hunan, China.
Clin Rheumatol. 2019 Nov;38(11):3253-3259. doi: 10.1007/s10067-019-04672-5. Epub 2019 Jul 20.
This study aimed at examining the association between symptomatic knee osteoarthritis and all-cause mortality based on four population-based longitudinal surveys.
Data were retrieved from the English Longitudinal Study of Aging (ELSA), the Survey of Health, Aging and Retirement in Europe (SHARE), the Korean Longitudinal Study of Aging (KLoSA), and the Indonesian Family Life Survey (IFLS). The association between symptomatic knee osteoarthritis and all-cause mortality over the 8- to 12-year follow-up period was assessed using Cox-proportional hazard models.
In the entire sample of 59,522 participants (4823 with symptomatic knee osteoarthritis; 54,699 without symptomatic knee osteoarthritis [control group]; mean age: 61.8 years; female percentage: 55.3%), 8375 died (937 in the symptomatic knee osteoarthritis group, 7438 in the control group) during the follow-up period. Patients with symptomatic knee osteoarthritis had a higher risk of all-cause mortality than control group without adjusting for potential confounders in each survey, and the unadjusted hazard ratios (HRs) of all-cause mortality were 1.32 (95% confidence interval [CI] 1.18 to 1.47) in ELSA, 1.40 (95%CI 1.24 to 1.56) in SHARE, 1.25 (95%CI 1.06 to 1.47) in KLoSA, and 1.65 (95%CI 1.31 to 2.07) in IFLS. However, with adjustment of potential confounders, the corresponding HRs dropped to 1.07 (95%CI 0.94 to 1.20) in ELSA, 1.08 (95%CI 0.97 to 1.22) in SHARE, 0.91 (95%CI 0.77 to 1.08) in KLoSA, and 0.89 (95%CI 0.66 to 1.21) in IFLS, respectively.
In these four population-based longitudinal studies, no association between symptomatic knee osteoarthritis and increased risk of all-cause mortality was observed after adjusting for potential confounders. Key Points • This study evaluated the association between symptomatic knee OA and the risk of all-cause mortality among the participants retrieved from four large population-based longitudinal studies across the world. • No association between symptomatic knee osteoarthritis and increased risk of all-cause mortality was observed after considering potential confounders, and our findings were consistent with the results derived from four independent longitudinal studies. • The present study included four international population-based longitudinal studies, comprising both developed and developing areas, which allowed the findings to be interpreted under larger circumstance.
本研究旨在基于四项基于人群的纵向研究,检验有症状膝关节骨关节炎与全因死亡率之间的关联。
数据来自英国老龄化纵向研究(ELSA)、欧洲健康、老龄化和退休调查(SHARE)、韩国老龄化纵向研究(KLoSA)和印度尼西亚家庭生活调查(IFLS)。使用 Cox 比例风险模型评估 8 至 12 年随访期间有症状膝关节骨关节炎与全因死亡率之间的关联。
在 59522 名参与者的整个样本中(4823 名患有有症状的膝关节骨关节炎;54699 名没有有症状的膝关节骨关节炎[对照组];平均年龄:61.8 岁;女性百分比:55.3%),8375 人在随访期间死亡(有症状的膝关节骨关节炎组 937 人,对照组 7438 人)。在未调整每个研究中潜在混杂因素的情况下,患有有症状膝关节骨关节炎的患者全因死亡率的风险高于对照组,未调整的全因死亡率的风险比(HR)分别为 ELSA 中的 1.32(95%置信区间[CI] 1.18 至 1.47)、SHARE 中的 1.40(95%CI 1.24 至 1.56)、KLoSA 中的 1.25(95%CI 1.06 至 1.47)和 IFLS 中的 1.65(95%CI 1.31 至 2.07)。然而,在调整潜在混杂因素后,相应的 HR 分别降至 ELSA 中的 1.07(95%CI 0.94 至 1.20)、SHARE 中的 1.08(95%CI 0.97 至 1.22)、KLoSA 中的 0.91(95%CI 0.77 至 1.08)和 IFLS 中的 0.89(95%CI 0.66 至 1.21)。
在这四项基于人群的纵向研究中,在调整潜在混杂因素后,有症状膝关节骨关节炎与全因死亡率增加之间没有关联。
本研究评估了从全球四项大型基于人群的纵向研究中检索到的有症状膝骨关节炎与全因死亡率风险之间的关系。
在考虑了潜在混杂因素后,没有发现有症状膝关节骨关节炎与全因死亡率增加之间存在关联,我们的发现与来自四项独立纵向研究的结果一致。
本研究纳入了四项国际基于人群的纵向研究,包括发达国家和发展中国家,这使得研究结果可以在更大的范围内进行解释。